IL10 and neoplasm: Nevertheless, anti-inflammatory responses mediated by IL-10 or the IL-4/STAT6 signaling pathway can favor those immune cells infiltrated into the tumor to acquire protumoral phenotypes such as tumor-associated macrophages (TAMs), which fuel the development and establishment of different types of tumors [9,31,32].